GCG and Hyperglycemia: Based on the obtained results, we assume that the reduction in inflammatory stress, of Ninj-1 in particular, together with the reduction in postprandial glucose by controlling the carbohydrate intake, food composition, physical exercise, and the use of medication such as sodium glucose transporter 2 inhibitors or glucagon-like peptide 1 agonists (considered safe compounds, able to reduce the postprandial hyperglycaemia with a low risk of hypoglycaemic events) in diabetic patients [72] could diminish the deleterious effects of postprandial hyperglycaemia and glucose oscillations.